Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.71 - $1.15 $7,759 - $12,568
10,929 New
10,929 $7,000
Q1 2023

May 15, 2023

SELL
$0.69 - $1.42 $7,902 - $16,263
-11,453 Reduced 36.15%
20,229 $14,000
Q4 2022

Feb 14, 2023

BUY
$0.63 - $0.97 $19,959 - $30,731
31,682 New
31,682 $20,000

Others Institutions Holding ONTX

About Onconova Therapeutics, Inc.


  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.